The continued crisis for harm reduction funding in low- and middle-income countries download (HRI)
Bibliography: All Publications
Crime in England and Wales: year ending December 2020
Rises in drug offences during 2020 compared with 2019 average (ONS)
Drug-related deaths and mortality in Europe: update from the EMCDDA expert network
This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deaths
Exploring drug supply, associated violence and exploitation of vulnerable groups in Denmark
This report provides an analysis of current drug supply models and the related violence and exploitation of vulnerable groups in Denmark (EMCDDA)
Parents with alcohol and drug problems: using case studies to estimate the cost-benefit of interventions
This guidance supports local areas, organisations and providers that have collected, or intend to collect, case studies to estimate how much social and economic cost they can avoid by supporting families experiencing alcohol and drug problems (Public Health England)
Parents with alcohol and drug problems: guidance for adult treatment and children and family services
The guidance outlines the main issues for families affected by parental alcohol and drug problems and shows how services can work together to support them (Public Health England)
Who’s more likely to be able to get naloxone (Narcan) at their pharmacy?
A look at the socioeconomic factors associated with naloxone availability (Recovery Research Institute)
Standard Operating Procedure for using evidence in ACMD reports
A document developed by the Advisory Council on the Misuse of Drugs (ACMD) to outline the governing process for preparing evidence-based advice
Methamphetamine developments in South Asia
The situation in Iran and the implications for the EU and its neighbours — EU4MD special report (EMCDDA)
Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons
The results from this study provide a first glimpse into new developments emerging both during and in response to the pandemic, and which could have important implications for the future (EMCDDA)
HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder
The Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder exempt eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives from federal certification requirements related to training, counseling and other ancillary services that are part of the process for obtaining a waiver to treat up to 30 patients with buprenorphine (SAMHSA)
Patterns of intensive alcohol and other drug treatment service use in Australia, 1 July 2014 to 30 June 2019
This report describes 3 distinct client cohorts based on their patterns of treatment service use between 1 July 2014 and 30 June 2019. Clients who received intensive treatment were more likely than other cohorts to report receiving treatment for multiple principal drugs of concern and for more main treatment types across episodes (AIHW)
Trends in Drug-Induced Deaths in Australia, 1997-2019
Preliminary estimates indicate that there were 1,865 drug-induced deaths among Australians in 2019. This is equivalent to over five drug-induced deaths per day. This is the fifth year in a row where the number of deaths is higher than the earlier peak in the late 1990s (NDARC)
Narcotic Drugs – Estimated World Requirements for 2021
The Report of the International Narcotics Control Board for 2020
Drug Decriminalisation: Progress or Political Red Herring?
Based on the findings from this study INPUD has drawn the following primary recommendations from this report
Taking stock of half a decade of drug policy – An evaluation of UNGASS implementation
This report aims to take stock of progress made on the implementation of the operational recommendations included in the UNGASS Outcome Document (idpc)
Examination of the links between parental conflict and substance misuse and the impacts on children’s outcomes
This report is a literature review examining the links between parental conflict and substance misuse and the impacts on children’s outcomes (UK Government)
Methamphetamine developments in South Asia: the situation in Iran and the implications for the EU and its neighbours — EU4MD special report
The report is the result of research conducted under the EU4Monitoring Drugs (EU4MD) project, funded by the European Commission (EMCDDA)
National Opioid Pharmacotherapy Statistics Annual Data collection
On a snapshot day in 2020, over 53,300 clients received pharmacotherapy treatment for their opioid dependence at 3,084 dosing points across Australia. There were 3,422 authorised prescribers of opioid pharmacotherapy drugs (AIHW)
‘High rollers’ A study of criminal profits along Australia’s heroin and methamphetamine supply chains
This report helps develop an understanding of the quantum of profits being made and where in the value chain they occur. Australians spent approximately A$5.8 billion on methamphetamine and A$470 million on heroin in FY 2019 (ASPI)
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 84
- Next Page »
